Study title: Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis - Greinacher A. et al. - 2005 (Thromb Haemost 2005; 94; 132-5) Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis - Greinacher A. et al. - 2005 (Thromb Haemost 2005; 94; 132-5)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Hemic and Lymphatic Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: HEPARIN | |||||
ATC code: B01AB01 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |